Menu

Flu Forecasters Predict This Year’s Season to Peak Early

Influenza cases normally top out in February. This year brought an early start and an early peak, but how long flu season will remain is uncertain. 

Jan 23, 2018
Christina Reed

ISTOCK, TERO VESALAINENThanks to years of highly accurate flu forecasts, modelers have been able to tip off health advisors this year to an early peak in flu cases in the U.S. that may already be tapering off.

“Our early forecasts [in the fall] weren’t giving us much information on the timing or intensity of this season—they were just matching historic trends,” says epidemiologist and modeler Matthew Biggerstaff of the Influenza Division in the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC). “But by the middle of December, we had good signals for an early season and can safely say now that we’ve confirmed this season started early and peaked early.”

Forecasts are giving us an 80 percent chance that we will see the peak before the end of January.—Matthew Biggerstaff,
CDC

Usually, the peak in the number of flu cases comes around February. This year’s forecasts are more closely matching the 2014-2015 season, which started early, peaked early in late December, and then lasted longer than any other season in more than a decade. So far, this season has seen 30 pediatric deaths, and in the last week of 2017, the mortality rates from pneumonia and influenza shot above the normal flu epidemic threshold by 1.1 percent. From October through mid-January, a total of 8,990 laboratory-confirmed, influenza-associated hospitalizations have been reported, most among adults aged 65 or older.

While this week is “a little too soon to see if we are going to go down, forecasts are giving us an 80 percent chance that we will see the peak before the end of January,” says Biggerstaff. It’s possible the peak already occurred weeks ago, but it takes some time for the data on cases to be processed.

The CDC has about two dozen academic teams, including two international groups, that are together providing 30 different forecasts of the 2017-2018 flu season in the United States. CDC requests forecasters to provide predictions for the four weeks ahead of the most-recent week for which the agency has published its incidence numbers. The reality check on the accuracy of these forecasts is measured by comparing them to influenza-like illness reports made to the CDC from its network of 2,000 health providers. The CDC then estimates the average prevalence of flu in the different regions across the United States.

See “How Bad Will the Flu Season Get? Forecasters Are Competing to Figure it Out”

But getting those reports, especially when the peak flu season coincides with end-of-the-year holidays, can take time. “Providers may have been closed or behind because they did not have enough staff over the holidays, so we need to wait to see” how accurately the forecasts match intensity estimates, says Biggerstaff. The CDC will do a preliminary evaluation of this season’s forecasts in March or April and a final evaluation in July.

“It means that we won’t really know how good our forecasts have been until the end of the season,” explains Roni Rosenfeld, whose team at Carnegie Mellon University’s Delphi Group has for last three years most accurately predicted each flu season’s start, peak, and intensity. When The Scientist spoke with Rosenfeld near the beginning of the season, last November, he said the peak in severity would come around the second to fourth week in January. After modifying that to earlier in the season, his team is once again calling for those weeks in January to experience the peak.

This year, with the virulent strain of H3N2 flu dominating reports of illness, more deaths and hospitalizations from the flu are expected this year. This makes predictions during mid-season critical for health care providers to plan for flu cases. But whether or not this season will end early or gradually decrease over a longer period of time is still too early to tell, explains Rosenfeld. 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.